1-115705257-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001232.4(CASQ2):c.874G>T(p.Ala292Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00018 in 1,613,998 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A292A) has been classified as Likely benign.
Frequency
Consequence
NM_001232.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CASQ2 | ENST00000261448.6 | c.874G>T | p.Ala292Ser | missense_variant | 9/11 | 1 | NM_001232.4 | ENSP00000261448.5 | ||
CASQ2 | ENST00000488931.2 | n.*246G>T | non_coding_transcript_exon_variant | 11/13 | 3 | ENSP00000518226.1 | ||||
CASQ2 | ENST00000488931.2 | n.*246G>T | 3_prime_UTR_variant | 11/13 | 3 | ENSP00000518226.1 |
Frequencies
GnomAD3 genomes AF: 0.000309 AC: 47AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000287 AC: 72AN: 251306Hom.: 0 AF XY: 0.000302 AC XY: 41AN XY: 135822
GnomAD4 exome AF: 0.000167 AC: 244AN: 1461698Hom.: 0 Cov.: 31 AF XY: 0.000168 AC XY: 122AN XY: 727164
GnomAD4 genome AF: 0.000309 AC: 47AN: 152300Hom.: 0 Cov.: 32 AF XY: 0.000416 AC XY: 31AN XY: 74468
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 03, 2015 | Variant classified as Uncertain Significance - Favor Benign. The p.Ala292Ser in CASQ2 has not been reported in individuals with cardiomopathy, but has been repo rted in 0.2% (13/6602) of Finnish chromosomes by the Exome Aggregation Consortiu m (ExAC, http://exac.broadinstitute.org; dbSNP rs200643387). Computational predi ction tools and conservation analysis do not provide strong support for or again st and impact to the protein. In summary, while the clinical significance of the p.Ala292Ser variant is uncertain, its frequency suggests that it is more likely to be benign. - |
Catecholaminergic polymorphic ventricular tachycardia 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Long QT syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Dept of Medical Biology, Uskudar University | Jan 08, 2024 | Criteria: BS1, PP3 - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 12, 2022 | The p.A292S variant (also known as c.874G>T), located in coding exon 9 of the CASQ2 gene, results from a G to T substitution at nucleotide position 874. The alanine at codon 292 is replaced by serine, an amino acid with similar properties. This alteration has been reported in a sudden cardiac death with myocardial fibrosis cohort and a hypertrophic cardiomyopathy cohort (Junttila MJ et al. Circulation, 2018 06;137:2716-2726; Jääskeläinen P et al. ESC Heart Fail, 2019 Apr;6:436-445). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Catecholaminergic polymorphic ventricular tachycardia 1 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at